Chargement de l’entreprise
Keep exploring
The themes Danaher is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Diagnostics and Research
Graded A or B and worth $2B or more: A first, then the largest.
TMOThermo Fisher Scientific Inc.259,4B $USA+
IDXXIdexx Laboratories Inc.55,5B $USA+
IQVIQVIA Holdings Inc.43,7B $USA
ILMNIllumina, Inc.31,3B $USA+
LHLabcorp Holdings Inc.30,1B $USA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
MCKMckesson Corporation4 nov. 2026BAGraded B, now A
CVSCVS Health Corp4 nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov. 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 oct. 2026CAGraded C, now A
BIIBBiogen Inc.28 oct. 2026BAGraded B, now A
Comment elle gagne de l'argent
- Biotechnology: equipment, supplies, and services for biological drug research and manufacturing30 %
- Life Sciences: research instruments, supplies, and filtration products30 %
- Diagnostics: instruments, tests, and patient-monitoring products40 %
Les parts du chiffre d'affaires sont des estimations pour six months ended June 26, 2026, pas des chiffres tirés d'un document officiel.
En concurrence avec
Ce qu'elle vend6
Cytiva bioprocessing products
Filters, resins, liquids, single-use equipment, and services that drugmakers use to develop and manufacture biological medicines.
Pall filtration products
Filters and related equipment that remove contaminants from liquids and gases used in medicine, research, food production, electronics manufacturing, and other industries.
Biacore 8S
A Cytiva instrument that lets researchers test how potential drug molecules interact with their targets.
Afficher 3 de plus
SCIEX mass spectrometers
Instruments that identify and measure molecules in samples, used in drug research, clinical testing, and food and environmental testing.
Beckman Coulter clinical testing systems
Laboratory instruments, tests, and software that analyze blood and other body samples to help diagnose and monitor health conditions.
Cepheid GeneXpert tests
Systems and tests that detect genetic material from organisms or diseases, including tests used in hospitals and other care settings.
Qui l'achète5
- Pharmaceutical and biotechnology companies buy research tools, drug-manufacturing equipment, and replacement supplies, often through Danaher's direct sales teams or distributors.
- Contract manufacturers and contract development organizations buy equipment, supplies, and services to make medicines for other companies.
- Universities, research institutes, and academic laboratories buy instruments and consumables for biological research.
Afficher 2 de plus
- Hospitals, doctors' offices, and reference laboratories buy diagnostic instruments, tests, and patient-monitoring products.
- Industrial customers, including semiconductor, food, energy, and aerospace businesses, buy filtration equipment and replacement filters.
Sur quoi elle repose, et ce qui pourrait la briser
Ce dont l'activité dépend
- 1Some specially specified or regulated components can be obtained from only one supplier or a limited number of suppliers, even though Danaher says no single supplier is material to the company as a whole.
- 2Danaher sells mainly through its own sales teams and also uses independent distributors; changes in distributor performance or customer purchasing patterns can affect sales.
- 3Sales depend in part on regulatory clearances and approvals, and on healthcare providers' ability to obtain payment or reimbursement for products and services.
Ce qui pourrait mal tourner
- 1Competitors and new technologies can take demand or lead to price reductions in Danaher's many product markets.
- 2Regulatory requirements for medical devices and diagnostic tests, along with changes in healthcare reimbursement and cost controls, can delay sales or affect what customers buy and pay.
- 3A few large commercial drug manufacturers delayed planned shipments of chromatography resins in the second quarter of 2026, illustrating how customer production schedules and facility readiness can shift biotechnology sales.
À propos de Danaher Corp.
Danaher owns more than 15 operating companies grouped into biotechnology, life sciences, and diagnostics. Their products help researchers study cells and other biological material, help drugmakers make biological medicines, and help healthcare workers test samples and monitor patients. Many products are used up or replaced regularly, so customers buy supplies as well as instruments and services.
- Siège
- Washington, D.C., United States
- Fondée en
- 1984
- Effectif
- Approximately 60,000 (as of December 31, 2025, high)
- Cotée sur
- NYSE
- Clôture de l'exercice
- December 31
Construit à partir des documents déposés par Danaher Corp. auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.